Clinical Sciences
Adverse effects of 0.01% atropine sulfate eye drops on myopic children
Aicun Fu, Bingxin Zhao, Junjie Zhang, Jinsong Zhang, Binbin Li, Xiuhong Li, Lina Shang, Yong Lyu
Published 2018-06-10
Cite as Chin J Exp Ophthalmol, 2018, 36(6): 449-453. DOI: 10.3760/cma.j.issn.2095-0160.2018.06.010
Abstract
ObjectiveTo observe the adverse effects of 0.01% atropine sulfate eye drops on myopic children.
MethodsA prospective non-randomized controlled trial was conducted.Ninety-nine myopic children (99 right eyes) were randomly assigned to experimental group(55 cases) and control group(44 cases). Myopic children of experimental group wore completely corrected frame glasses, while 0.01% atropine sulfate eye drop was dropped into each eye once a day before going to bed.Myopic children in control group only wore completely corrected frame glasses.The follow-up time was 4 months.Best corrected visual acuity (BCVA), intraocular pressure (IOP), change of pupil diameter (PD) and amplitude of accommodation, symptoms of discomfort after medication were observed.This study followed the Helsinki declaration and was approved by Ethic Committee of the First Affiliated Hospital of Zhengzhou University.Informed consent was signed by the parents of each patient.
ResultsNo significant differences were found in best corrected distance visual acuity (BCDVA), best corrected near visual acuity(BCNVA) and IOP between the two groups before and 4 months after treatment (BCDVA: Fgroup=3.880, P=0.112; Ftime=27.220, P=0.413; BCNVA: Fgroup=5.200, P=0.311; Ftime=38.200, P=0.116, IOP: Fgroup=12.350, P=0.214; Ftime=22.300, P=0.146). After 4 months treatment, the PD was (6.99±0.64)mm in the experimental group, which was significantly higher than that before treatment(P<0.001). The PD of the experimental group was higher than that of the control group after 4 months treatment, and the difference was statistically significant (P<0.01). The amplitude of accommodation in the experimental group was 14.01±3.98 after 4 months treatment.which was 1.20 D lower than that before treatment, the difference was statistically significant(P<0.01). The amplitude of accommodation of the experimental group was lower than that of the control group after 4 months treatment, the difference was statistically significant (P<0.01). Four cases (8%) appeared photophobia symptoms.Two cases and 2 cases appeared photophobia for 1 week or 2 weeks, respectively.However this symptom would relieve after wear sunglasses or sunshade caps in outdoor activities.One case (2%) appeared ocular itching and swelling after 1 month treatment, but disappeared after withdrawal.There were no other uncomfortable symptoms such as near sight blurring.
ConclusionsIn mainland of China, the BCDVA, BCNVA and IOP of myopic children are stable; the PD is dilated and the amplitude of accommodation is decreased slightly after 4 months treatment of 0.01% atropine, and 10% children appear photophobia, but do not affect their study and life.
Key words:
0.01% Atropine sulfate; Myopic children; Side effects; Pupil diameter; Amplitude of accommodation; Non-randomized controlled trial
Contributor Information
Aicun Fu
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Bingxin Zhao
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Junjie Zhang
Henan Eye Institute, Henan Eye Hospital, Henan Provincial People's Hospital, Zhengzhou 450003, China
Jinsong Zhang
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Binbin Li
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Xiuhong Li
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Lina Shang
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Yong Lyu
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
